Document Classification

Section Type: RESULTS

Text: Compared with control group, complete response for acute nausea and vomiting in test group had no difference (p > 0. 05), complete response for delayed nausea and vomiting in patients with highly emetogenic chemotherapy respectively improved 39. 21 % (69. 64 % versus 30. 43 %, p < 0. 05), 22. 05 % (78. 57 % versus 56. 52 %, p < 0. 05), complete response for delayed nausea and vomiting in patients with moderately emetogenic chemotherapy respectively improved 25. 01 % (83. 07 % versus 58. 06 %, p < 0. 05), 13. 43 % (89. 23 % versus 75. 80 %, p < 0. 05), complete response for the whole period of nausea and vomiting in patients with highly emetogenic chemotherapy respectively improved 41. 38 % (69. 64 % versus 28. 26 %, p < 0. 05), 22. 05 % (78. 57 % versus 56. 52 %, p < 0. 05), complete response for the whole period of nausea and vomiting in patients with moderately emetogenic chemotherapy respectively improved 26. 62 % (83. 07 % versus 56. 45 %, p < 0. 05), 13. 43 % (89. 23 % versus 75. 80 %, p < 0. 05).